Long-term Survival After Chemoradiotherapy Without Surgery for Rectal Adenocarcinoma: A Word of Caution

Affiliations

¹ Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill.
² Eshelman School of Pharmacy, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.
³ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.
⁴ Division of Surgical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.

C Tyler Ellis et al. JAMA Oncol. 2017.

. 2017 Jan 1;3(1):123-125.

doi: 10.1001/jamaoncol.2016.3424.

¹ Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill.
² Eshelman School of Pharmacy, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.
³ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.
⁴ Division of Surgical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.

No abstract available

Figures

Inferior Survival Rates After Chemoradiation for Rectal Cancer Without Surgery.
Habr-Gama A, Julião GPS, Perez RO. Habr-Gama A, et al. JAMA Oncol. 2017 Jun 1;3(6):859. doi: 10.1001/jamaoncol.2016.6618. JAMA Oncol. 2017. PMID: 28448642 No abstract available.
Inferior Survival Rates After Chemoradiation for Rectal Cancer Without Surgery-Reply.
Ellis CT, Sanoff H, Stitzenberg KB. Ellis CT, et al. JAMA Oncol. 2017 Jun 1;3(6):859-860. doi: 10.1001/jamaoncol.2017.0407. JAMA Oncol. 2017. PMID: 28448650 No abstract available.
Gastrointestinal Cancers: Timing Is Everything.
Apisarnthanarax S, Jabbour SK, Liauw SL, Murphy JD, Olsen JR, Chang DT. Apisarnthanarax S, et al. Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1051-1058. doi: 10.1016/j.ijrobp.2017.05.040. Int J Radiat Oncol Biol Phys. 2017. PMID: 29165271 Free PMC article. No abstract available.

1. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011; 29(35):4633–4640. - PubMed
1. Habr-Gama A, Gama-Rodrigues J, São Julião GP, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys. 2014;88(4):822–828. - PubMed
1. Appelt AL, Pløen J, Harling H, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015;16(8):919–927. - PubMed
1. Smith JJ, Chow OS, Eaton A, et al. Organ preservation in patients with rectal cancer with clinical complete response after neoadjuvant therapy. J Clin Oncol. 2015;33(3)(suppl):509.
1. Renehan AG, Malcomson L, Emsley R, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016;17(2):174–183. - PubMed